Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $31.39 USD
Change Today +0.99 / 3.26%
Volume 1.6M
MDCO On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William B. O'Connor

Chief Accounting Officer and Senior Vice President, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

56$1,219,736
As of Fiscal Year 2014

Background*

Mr. William B. O'Connor, also known as Bill, served as a Senior Vice President of the Medicines Company and its Chief Accounting Officer since February 2008. Mr. O'Connor joined Medicines Co. in April 2006 as Vice President of Finance and Controller. Mr. O'Connor has 14 years of experience in the public accounting sector. From April 2000 to February 2006, he served as Vice President of Finance for Eyetech Pharmaceuticals, Inc. From 1996 to April 2000, Mr. O'Connor worked ...

Read Full Background

Corporate Headquarters*

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Fairleigh Dickinson University

Other Affiliations*

Annual Compensation*

Salary$393,750
Total Annual Compensation$393,750

Stock Options*

Restricted Stock Awards$320,897
All Other Compensation$3,124
Exercised Options76,811
Exercised Options Value$1,586,316
Exercisable Options93,987
Exercisable Options Value$581,743
Unexercisable Options31,952
Unexercisable Options Value$47,035
Total Value of Options$2,215,094
Total Number of Options202,750

Total Compensation*

Total Annual Cash Compensation$579,968
Total Short Term Compensation$393,750
Other Long Term Compensation$324,021
Total Calculated Compensation$1,219,736
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $31.39 USD +0.99

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter J. Arduini Chief Executive Officer, President, Director and Member of Special Award Committee
Integra LifeSciences Holdings Corporation
$827.8K
Dame Pamela Louise Makin MA, Ph.D.(Cantab), MBA, DBEChief Executive Officer and Executive Director
BTG plc
1.1M GBP
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Joze Colaric President of Management Board and Chief Executive Officer
KrKa dd Novo Mesto
€758.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.